trial
as of 2026-07-01ReMindCare App for Patients From First Episode of Psychosis Unit.
NCTId NCT03807388
at a glance
— · Unknown
Enrollment 140 (estimated)
Sponsored by Instituto de Investigacion Sanitaria INCLIVA
Primary completion 2020-05
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
140 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-09
Primary completion
2020-05
Eligibility
ALL · 17 Years · 65 Years
Interventions & indications
Sponsors
Instituto de Investigacion Sanitaria INCLIVALead Sponsor
University of ValenciaCollaborator
Universitat Politècnica de ValènciaCollaborator
Hospital Clínico Universitario de ValenciaCollaborator
Investigators
1
Julio SanjuánStudy Director
Sites
1 total
Valencia, Spain
Facts & assertions
4 sourced
Enrollment
140
Phase
NA
Primary Completion Date
2020-05
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person